Carregant...
Lung Shunt Reduction for Yttrium-90 Radioembolization: Chemoembolization Versus Radioembolization
Aim: To evaluate the efficacy of chemoembolization versus radioembolization in reducing lung shunt fraction (LSF) in patients with hepatocellular carcinoma (HCC). Patients and Methods: In this retrospective study, from March 2012 to January 2021, 457 patients with HCC underwent planning angiography...
Guardat en:
| Publicat a: | In Vivo |
|---|---|
| Autors principals: | , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
International Institute of Anticancer Research
2021
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8286473/ https://ncbi.nlm.nih.gov/pubmed/34182510 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21873/invivo.12504 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|